{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:23:15Z","timestamp":1793910195760,"version":"4.8.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To provide an update of the prevalence and incidence of axial spondyloarthritis in the general population and in patients with spondyloarthritis-related conditions, environmental risk factors for ankylosing spondylitis, progression from nonradiographic axial spondyloarthritis to ankylosing spondylitis, mortality, and risks for cardiovascular events in patients with ankylosing spondylitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Increasingly, administrative healthcare data have been used to study disease frequency and outcomes. The prevalence of ankylosing spondylitis ranged from 9 to 30 per 10\u200a000 persons, which are lower than previous estimates. Data on whether childhood infections influence the risk of ankylosing spondylitis were equivocal, while having been breast-fed may be protective. Progression of patients with nonradiographic axial spondyloarthritis to ankylosing spondylitis is slow, with estimates of 5.1% in 5 years and 19% in 10 years. Risk of mortality is slightly increased in ankylosing spondylitis. Risks for cardiovascular events in ankylosing spondylitis were either not different from, or only slightly higher than in controls. No studies have examined these outcomes in the broader group of patients with axial spondyloarthritis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Expanded use of administrative and registry data has facilitated studies of the epidemiology of ankylosing spondylitis, but lack of specific diagnostic codes limits use of these resources for studying axial spondyloarthritis in general.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000475","type":"journal-article","created":{"date-parts":[[2017,12,9]],"date-time":"2017-12-09T20:13:15Z","timestamp":1512850395000},"page":"137-143","source":"Crossref","is-referenced-by-count":188,"title":["Epidemiology of axial spondyloarthritis: an update"],"prefix":"10.1097","volume":"30","author":[{"given":"Runsheng","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Ward","sequence":"additional","affiliation":[{"name":"Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230928","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13075-015-0627-0","article-title":"The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study","volume":"17","author":"Exarchou","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/acr.22959","article-title":"Inflammatory Arthritis prevalence and health services use in the first nations and non\u2013first nations populations of Alberta, Canada","volume":"69","author":"Barnabe","year":"2017","journal-title":"Arthritis Care Res(Hoboken)"},{"key":"R3-20230928","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/rheumatology\/kew228","article-title":"Differences in the prevalence of ankylosing spondylitis in primary and secondary care: only one-third of patients are managed in rheumatology","volume":"55","author":"Dean","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"e0138492","DOI":"10.1371\/journal.pone.0138492","article-title":"Changes in the prevalence of rheumatic diseases in Shantou, China, in the past three decades: a COPCORD study","volume":"10","author":"Zeng","year":"2015","journal-title":"PLoS One"},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10067-015-3148-y","article-title":"Epidemiology of rheumatic diseases in Mixtec and Chontal indigenous communities in Mexico: a cross-sectional community-based study","volume":"35","author":"Juli\u00e1n-Santiago","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7812\/TPP\/15-151","article-title":"Diagnostic prevalence of ankylosing spondylitis using computerized healthcare data, 1996 to 2009: underrecognition in a US healthcare setting","volume":"20","author":"Curtis","year":"2016","journal-title":"Perm J"},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/annrheumdis-2013-204436","article-title":"Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort","volume":"74","author":"Costantino","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.22831","article-title":"Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R9-20230928","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/acr.22512","article-title":"Time trends in incidence, clinical features, and cardiovascular disease in ankylosing spondylitis over three decades: a population-based study","volume":"67","author":"Wright","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R10-20230928","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/pds.3952","article-title":"Validity of ankylosing spondylitis diagnoses in The Health Improvement Network","volume":"25","author":"Dubreuil","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/acr.23140","article-title":"Identifying axial spondyloarthritis in electronic medical records of United States Veterans","volume":"69","author":"Walsh","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R12-20230928","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/art.39766","article-title":"Clinical and imaging signs of spondyloarthritis in first-degree relatives of HLA-B27-positive ankylosing spondylitis patients: the Pre-Spondyloarthritis (Pre-SpA) Cohort Study","volume":"68","author":"Turina","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/art.39612","article-title":"Frequency of axial spondyloarthritis diagnosis among patients seen by US rheumatologists for evaluation of chronic back pain","volume":"68","author":"Deodhar","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/acr.22528","article-title":"Prevalence of chronic axial pain, inflammatory back pain, and spondyloarthritis in diagnosed psoriasis","volume":"67","author":"Thom","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R15-20230928","article-title":"Prevalence of sacroiliitis in inflammatory bowel disease using a standardized CT scoring system","author":"Chan","year":"2017","journal-title":"Arthritis Care Res"},{"key":"R16-20230928","first-page":"631","article-title":"The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Karreman","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R17-20230928","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/art.39542","article-title":"Progression of nonradiographic axial spondyloarthritis to ankylosing spondylitis: a population-based cohort study","volume":"68","author":"Wang","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R18-20230928","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/rheumatology\/kew496","article-title":"Radiographic sacroiliitis develops predictably over time in a cohort of familial spondyloarthritis followed longitudinally","volume":"56","author":"Costantino","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/art.39666","article-title":"Rate and predisposing factors for sacroiliac joint radiographic progression after a two-year follow-up period in recent-onset spondyloarthritis","volume":"68","author":"Dougados","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R20-20230928","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/ard.2010.145995","article-title":"Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis","volume":"70","author":"Poddubnyy","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R21-20230928","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/annrheumdis-2017-211596","article-title":"Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort","volume":"76","author":"Dougados","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R22-20230928","doi-asserted-by":"crossref","first-page":"e5960","DOI":"10.1097\/MD.0000000000005960","article-title":"Progression rate of ankylosing spondylitis in patients with undifferentiated spondyloarthritis","volume":"96","author":"Xia","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R23-20230928","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/annrheumdis-2015-208187","article-title":"Patients with ankylosing spondylitis have been breast fed less often than healthy controls: a case-control retrospective study","volume":"75","author":"Montoya","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R24-20230928","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13075-016-1141-8","article-title":"Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study","volume":"18","author":"Lindstr\u00f6m","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R25-20230928","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13075-016-0917-1","article-title":"Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers","volume":"18","author":"Lindstr\u00f6m","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R26-20230928","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","article-title":"Mortality in ankylosing spondylitis: results from a nationwide population-based study","volume":"75","author":"Exarchou","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R27-20230928","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1136\/annrheumdis-2017-211253","article-title":"Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study","volume":"76","author":"Oza","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R28-20230928","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann Intern Med"},{"key":"R29-20230928","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/annrheumdis-2016-209315","article-title":"Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?","volume":"76","author":"Eriksson","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R30-20230928","doi-asserted-by":"crossref","first-page":"e3596","DOI":"10.1097\/MD.0000000000003596","article-title":"Midlife ankylosing spondylitis increases the risk of cardiovascular diseases in males 5 years later: a national population-based study","volume":"95","author":"Hung","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R31-20230928","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/annrheumdis-2014-206147","article-title":"Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study","volume":"75","author":"Essers","year":"2016","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201803000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T02:03:54Z","timestamp":1695866634000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201803000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000475","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}